Release Coating Composition With Metal-Ligand Catalyst Bathlife
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional silicone compositions for forming release coatings face compatibility issues with inhibitors and hydrosilylation reaction catalysts, leading to reduced bathlife and performance inconsistencies.
Innovation Solution
A composition comprising an organopolysiloxane with silicon-bonded ethylenically unsaturated groups and a hydrosilylation catalyst in the form of a metal-ligand complex, which enhances stability and extends bathlife.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Duration of action of moving object
If inhibitors are included in conventional compositions to extend bathlife, then working life is extended, but compatibility issues arise that reduce performance properties
Solution Approach 1:
The patent introduces a specific metal-ligand complex catalyst system with carefully selected ligands that act as intermediaries between the catalyst and reactants. This intermediary catalyst system enables extended bathlife without the harmful compatibility issues of conventional inhibitors, as the ligand-modified catalyst maintains stability while facilitating the hydrosilylation reaction.
Solution Approach 2:
The patent changes the chemical parameters of the catalyst system by using metal-ligand complexes with specific ligand formulas (where R1-R9 are specific organic groups and E is C or Si). This parameter change allows the catalyst to operate with extended bathlife while maintaining compatibility and performance, avoiding the trade-off present in conventional inhibitor-based systems.
2Ease of manufacture
If hydrosilylation reaction catalysts are used to form release coatings, then curing is enabled, but compatibility issues with inhibitors reduce bathlife
Solution Approach 1:
The patent employs metal-ligand complex catalysts where the ligands serve as intermediaries that mediate between the metal center and the reactants. This intermediary catalyst structure enables reliable curing while extending bathlife, as the ligand shell protects the catalyst from premature reaction and maintains compatibility with other composition components.
Solution Approach 2:
The patent creates a composite catalyst system combining metal centers with organic ligands (where each L has specific R1-R9 groups). This composite catalyst structure integrates the catalytic activity needed for curing with the stability required for extended bathlife, resolving the compatibility issue between catalysts and inhibitors in conventional systems.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The composition provides excellent stability at room temperature, resulting in an extended bathlife and improved performance of release coatings.
Implementation Method 1
Conventional release liners are typically formed by addition reacting (or hydrosilylating) an organopolysiloxane having an unsaturated hydrocarbon group and an organohydrogenpolysiloxane in the presence of a hydrosilylation reaction catalyst
Implementation Method 2
addition reacting (or hydrosilylating) an organopolysiloxane having an unsaturated hydrocarbon group and an organohydrogenpolysiloxane
Data Source
AI summary
A composition for forming a release coating comprises (A) an organopolysiloxane comprising at least one RSiO3/2 siloxy unit or at least one SiO4/2 siloxy unit, where R is a substituted or unsubstituted hydrocarbyl group. The (A) organopolysiloxane has an average of at least two silicon-bonded ethylenically unsaturated groups per molecule. The composition further comprises (B) an organosilicon compound having an average of at least two silicon-bonded hydrogen atoms per molecule. Finally, the composition comprises (C) a hydrosilylation catalyst comprising a metal-ligand complex having the formula MLxDy, wherein M is a metal: x is equal to the oxidation state of M: each D is independently a neutral coordinating ligand: y is zero or an integer from 1 to 4; and each L is a mono-anionic ligand having a certain formula.